The agency also said that Medicare beneficiaries will for the first time be able to choose prescription drug plans that include broad sets of insulin priced at no more than $35 per month, per prescription.
Earlier this year, CMS launched its Part D senior savings model, which caps monthly insulin copays at $35. The agency predicts the program will save beneficiaries an average of $446 per year.
CMS said that Part D premiums have decreased by 12 percent since 2017, and enrollment has increased by 16.7 percent during the same time period.
Read CMS’ full news release here.
More articles on pharmacy:
Moderna’s coronavirus vaccine research alleged target of Chinese hackers
Operation Warp Speed: a timeline so far
25% of diabetes patients rationing treatments amid pandemic, survey finds